Seres therapeutics reports qtrly loss per share of $0.23

Seres therapeutics reports third quarter financial results and provides business update.qtrly loss per share $0.23.qtrly total revenue $7 million versus $9.1 million.q3 earnings per share view $-0.32, revenue view $6.7 million -- refinitiv ibes data.

MCRB Ratings Summary

MCRB Quant Ranking